128 related articles for article (PubMed ID: 34333121)
21. Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.
Hosokawa T; Nakajima H; Unoda K; Yamane K; Doi Y; Ishida S; Kimura F; Hanafusa T
J Neurol; 2016 Sep; 263(9):1709-18. PubMed ID: 27278064
[TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients.
Camdessanché JP; Antoine JC; Honnorat J; Vial C; Petiot P; Convers P; Michel D
Brain; 2002 Jan; 125(Pt 1):166-75. PubMed ID: 11834602
[TBL] [Abstract][Full Text] [Related]
23. Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.
Berciano J; Sedano MJ; Pelayo-Negro AL; García A; Orizaola P; Gallardo E; Lafarga M; Berciano MT; Jacobs BC
J Neurol; 2017 Feb; 264(2):221-236. PubMed ID: 27314967
[TBL] [Abstract][Full Text] [Related]
24. COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy.
Garnero M; Del Sette M; Assini A; Beronio A; Capello E; Cabona C; Reni L; Serrati C; Bandini F; Granata A; Pesce G; Mancardi GL; Uccelli A; Schenone A; Benedetti L
J Neurol Sci; 2020 Nov; 418():117114. PubMed ID: 32947089
[TBL] [Abstract][Full Text] [Related]
25. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.
Alanazy MH; Bakry SS; Alqahtani A; AlAkeel NS; Alazwary N; Osman AM; Mustafa RA; Al-Harbi TM; Abdulmana SO; Amper AC; Aldughaythir Y; Ali AS; Makkawi S; Maglan A; Alamoudi L; Alsulaiman F; Alabdali M; AlShareef AA; Abuzinadah AR; Bamaga AK
BMC Neurol; 2021 Jul; 21(1):275. PubMed ID: 34253174
[TBL] [Abstract][Full Text] [Related]
26. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
Keddie S; Pakpoor J; Mousele C; Pipis M; Machado PM; Foster M; Record CJ; Keh RYS; Fehmi J; Paterson RW; Bharambe V; Clayton LM; Allen C; Price O; Wall J; Kiss-Csenki A; Rathnasabapathi DP; Geraldes R; Yermakova T; King-Robson J; Zosmer M; Rajakulendran S; Sumaria S; Farmer SF; Nortley R; Marshall CR; Newman EJ; Nirmalananthan N; Kumar G; Pinto AA; Holt J; Lavin TM; Brennan KM; Zandi MS; Jayaseelan DL; Pritchard J; Hadden RDM; Manji H; Willison HJ; Rinaldi S; Carr AS; Lunn MP
Brain; 2021 Mar; 144(2):682-693. PubMed ID: 33313649
[TBL] [Abstract][Full Text] [Related]
27. Sural sparing in Guillain-Barré syndrome subtypes: a reappraisal with historical and recent definitions.
Hiew FL; Rajabally YA
Clin Neurophysiol; 2016 Feb; 127(2):1683-1688. PubMed ID: 26459671
[TBL] [Abstract][Full Text] [Related]
28. Review article on COVID-19 and Guillain-Barré syndrome.
Patnaik UJ
Front Biosci (Schol Ed); 2021 Jun; 13(1):97-104. PubMed ID: 34256532
[TBL] [Abstract][Full Text] [Related]
29. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
Agha Abbaslou M; Karbasi M; Mozhdehipanah H
Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
[TBL] [Abstract][Full Text] [Related]
30. Electrodiagnostic and clinical aspects of Guillain-Barré syndrome: an analysis of 142 cases.
Gupta D; Nair M; Baheti NN; Sarma PS; Kuruvilla A;
J Clin Neuromuscul Dis; 2008 Dec; 10(2):42-51. PubMed ID: 19169089
[TBL] [Abstract][Full Text] [Related]
31. Very early electrodiagnostic findings in Guillain-Barré syndrome.
Albertí MA; Alentorn A; Martínez-Yelamos S; Martínez-Matos JA; Povedano M; Montero J; Casasnovas C
J Peripher Nerv Syst; 2011 Jun; 16(2):136-42. PubMed ID: 21692913
[TBL] [Abstract][Full Text] [Related]
32. Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
Samukawa M; Hamada Y; Kuwahara M; Takada K; Hirano M; Mitsui Y; Sonoo M; Kusunoki S;
J Neurol Sci; 2014 Feb; 337(1-2):55-60. PubMed ID: 24289889
[TBL] [Abstract][Full Text] [Related]
33. Peripheral neuropathy in COVID-19 is due to immune-mechanisms, pre-existing risk factors, anti-viral drugs, or bedding in the Intensive Care Unit.
Finsterer J; Scorza FA; Scorza CA; Fiorini AC
Arq Neuropsiquiatr; 2021 Oct; 79(10):924-928. PubMed ID: 34287509
[TBL] [Abstract][Full Text] [Related]
34. Role of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome.
Kalita J; Kumar M; Misra UK
Pediatr Crit Care Med; 2019 Jul; 20(7):652-659. PubMed ID: 30985608
[TBL] [Abstract][Full Text] [Related]
35. Comparison of electrophysiological findings in axonal and demyelinating Guillain-Barre syndrome.
Yadegari S; Nafissi S; Kazemi N
Iran J Neurol; 2014 Jul; 13(3):138-43. PubMed ID: 25422732
[TBL] [Abstract][Full Text] [Related]
36. Case Report: Guillain-Barré Syndrome Associated With COVID-19.
Khedr EM; Shoyb A; Mohamed KO; Karim AA; Saber M
Front Neurol; 2021; 12():678136. PubMed ID: 34239495
[TBL] [Abstract][Full Text] [Related]
37. A Case of Guillain-Barré Syndrome Associated With COVID-19.
Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
[TBL] [Abstract][Full Text] [Related]
38. Guillain-Barre syndrome associated to COVID-19 infection: a review of published case reports.
Zuberbühler P; Conti ME; León-Cejas L; Maximiliano-González F; Bonardo P; Miquelini A; Halfon J; Martínez J; Gutiérrez MV; Reisin R
Rev Neurol; 2021 Mar; 72(6):203-212. PubMed ID: 33710610
[TBL] [Abstract][Full Text] [Related]
39. Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.
Puma A; Benoit J; Sacconi S; Uncini A
BMC Neurol; 2018 Jul; 18(1):101. PubMed ID: 30031375
[TBL] [Abstract][Full Text] [Related]
40. A unicenter, prospective study of Guillain-Barré syndrome in Spain.
Sedano MJ; Orizaola P; Gallardo E; García A; Pelayo-Negro AL; Sánchez-Juan P; Infante J; Berciano J
Acta Neurol Scand; 2019 Jun; 139(6):546-554. PubMed ID: 30929269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
